These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38641422)

  • 21. Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA.
    Honeycutt S; Green R; Ballard D; Hermstad A; Brueder A; Haardörfer R; Yam J; Arriola KJ
    Cancer; 2013 Aug; 119(16):3059-66. PubMed ID: 23719894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities.
    Christie J; Itzkowitz S; Lihau-Nkanza I; Castillo A; Redd W; Jandorf L
    J Natl Med Assoc; 2008 Mar; 100(3):278-84. PubMed ID: 18390020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bridging the Gap: Patient Navigation Increases Colonoscopy Follow-up After Abnormal FIT.
    Idos GE; Bonner JD; Haghighat S; Gainey C; Shen S; Mulgonkar A; Otero KJ; Geronimo C; Hurtado M; Myers C; Morales-Pichardo J; Kahana DD; Giboney P; Dea S
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00307. PubMed ID: 33617188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Navigation Plus Tailored Digital Video Disc Increases Colorectal Cancer Screening Among Low-Income and Minority Patients Who Did Not Attend a Scheduled Screening Colonoscopy: A Randomized Trial.
    Rawl SM; Perkins SM; Tong Y; Katz ML; Carter-Bawa L; Imperiale TF; Schwartz PH; Fatima H; Krier C; Tharp K; Shedd-Steele R; Magnarella M; Malloy C; Haunert L; Gebregziabher N; Paskett ED; Champion V
    Ann Behav Med; 2024 Apr; 58(5):314-327. PubMed ID: 38470961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network.
    Percac-Lima S; López L; Ashburner JM; Green AR; Atlas SJ
    Cancer; 2014 Jul; 120(13):2025-31. PubMed ID: 24691564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. r.
    Devereux PG; Gray J; Robinson S; Galvin J; Gutierrez J
    Health Promot Pract; 2019 Jan; 20(1):85-93. PubMed ID: 29421953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effects of the Nurse Navigation Program in Promoting Colorectal Cancer Screening Behaviors: a Randomized Controlled Trial.
    Temucin E; Nahcivan NO
    J Cancer Educ; 2020 Feb; 35(1):112-124. PubMed ID: 30470978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
    Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
    J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hub-and-Spoke centralized intervention to optimize colorectal cancer screening and follow-up: A pragmatic, cluster-randomized controlled trial protocol.
    Castañeda SF; Gupta S; Nodora JN; Largaespada V; Roesch SC; Rabin BA; Covin J; Ortwine K; Preciado-Hidalgo Y; Howard N; Halpern MT; Martinez ME
    Contemp Clin Trials; 2023 Nov; 134():107353. PubMed ID: 37802222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing Colorectal Cancer Screening at an Urban FQHC Using iFOBT and Patient Navigation.
    Martin RL; Tully M; Kos A; Frazer D; Williamson A; Conlon A; Enser JJ; LoConte NK
    Health Promot Pract; 2017 Sep; 18(5):741-750. PubMed ID: 28812930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
    Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
    [No Abstract]   [Full Text] [Related]  

  • 36. Promoting colonoscopy screening among low-income Latinos at average risk of colorectal cancer: A randomized clinical trial.
    DuHamel KN; Schofield EA; Villagra C; Sriphanlop P; Itzkowitz SH; Cotter G; Cohen N; Erwin DO; Winkel G; Thompson HS; Zauber AG; Jandorf LH
    Cancer; 2020 Feb; 126(4):782-791. PubMed ID: 31742670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.
    Cusumano VT; Myint A; Corona E; Yang L; Bocek J; Lopez AG; Huang MZ; Raja N; Dermenchyan A; Roh L; Han M; Croymans D; May FP
    Dig Dis Sci; 2021 Nov; 66(11):3760-3768. PubMed ID: 33609211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying barriers to colonoscopy screening for nonadherent African American participants in a patient navigation intervention.
    Sly JR; Edwards T; Shelton RC; Jandorf L
    Health Educ Behav; 2013 Aug; 40(4):449-57. PubMed ID: 23086556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.
    Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00010. PubMed ID: 30829917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults.
    Horne HN; Phelan-Emrick DF; Pollack CE; Markakis D; Wenzel J; Ahmed S; Garza MA; Shapiro GR; Bone LR; Johnson LB; Ford JG
    Cancer Causes Control; 2015 Feb; 26(2):239-246. PubMed ID: 25516073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.